# NYSTATIN
> **ANDA203621** · Abbreviated New Drug Application (Generic) · Sponsor: PHARM ASSOC · Approved 2016-01-07
## Drug
- **FDA Application Number:** ANDA203621
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NYSTATIN
- **Generic name:** NYSTATIN
- **Active ingredients:** NYSTATIN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PHARM ASSOC
- **Manufacturer:** Pharmaceutical Associates, Inc.
- **First approval:** 2016-01-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203621)
---
*AI Analytics · CC0 1.0*